News Conference News VIVA 2024 Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care L.A. McKeown November 07, 2024
News Conference News ESC 2024 New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document Caitlin E. Cox September 10, 2024
News Conference News CRT 2024 CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care L.A. McKeown March 20, 2024
News Conference News SCAI 2023 CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI L.A. McKeown May 25, 2023
News Conference News SCAI 2023 Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI L.A. McKeown May 24, 2023
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ACC 2021 Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions L.A. McKeown May 21, 2021
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News LINC 2020 Lutonix BTK Studies: Below-the-Knee Challenges Linger L.A. McKeown January 29, 2020
News Conference News ISET 2020 FDA’s First Take on New Paclitaxel Concerns in CLI Caitlin E. Cox January 24, 2020
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News ISET 2017 Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not? Caitlin E. Cox February 06, 2017